Revenio as an investment

[Juha_Kinnunen]

@JNivala

Thanks @Juha_Kinnunen for the good answers as always That was new to me that Revenio’s imaging devices are specifically competitive in terms of price with those margins if one only considers customer costs. I would still like to ask if this information, e.g., about DRSplus’s more affordable price compared to competitors, came directly from Revenio’s management or from where?

Thank you. I don’t have notes here now, but I believe Revenio’s management has also confirmed that. I can ask about it once we get past this quiet period and into normal communication. I still emphasize that comparing these prices is a bit difficult. A fundus image can be taken with many different types of devices, and there’s a risk of comparing apples and pears when the device features differ. But my understanding is indeed that DRSplus is a relatively affordable device, performs its task very well, and doesn’t include any frills, which makes it a good device for a large part of the market (good market fit). But we’ll get back to it!